← Open Payments lookup

VEDA VARADA: Open Payments

NPI 1043979420 · RICHLAND, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,712 in 63 payments from 10 companies in 2025. Trend: 2023 $1,086 · 2024 $1,654 · 2025 $1,712

Food & beverage: $1,712
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.7$384
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)22$382
Axsome Therapeutics, Inc.6$308
Otsuka America Pharmaceutical, Inc.14$255
Alkermes, Inc.5$128
Supernus Pharmaceuticals, Inc.3$78
Takeda Pharmaceuticals U.S.A., Inc.2$58
Vanda Pharmaceuticals Inc.2$57
E.R. Squibb & Sons, L.L.C.1$38
Lundbeck LLC1$24

Products named: INGREZZA, CAPLYTA, Auvelity, REXULTI, ARISTADA, Qelbree, TRINTELLIX, FANAPT.

Industry payments across WA — which companies pay providers there.